BCL11A-triggered IFI6 inhibition reduces glioma cell resistance to temozolomide by promoting ferroptosis. Xu H, Lu J, Wu L, Wang H, et al. Neurol Res 2025 Dec 10:1-13. doi: 10.1080/01616412.2025.2592118.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu H, Lu J, Wu L, Wang H, et al. BCL11A-triggered IFI6 inhibition reduces glioma cell resistance to temozolomide by promoting ferroptosis. Neurol Res 2025 Dec 10:1-13. doi: 10.1080/01616412.2025.2592118.
PMID: 41368721